• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Geographic Variation in NAFLD Prevalence and Subspecialty Care Utilization Among Insured Adults in the United States.

作者信息

Gedallovich Seren M, Stephen John, Kang Raymond, Ackermann Ronald T, Ladner Daniela P, VanWagner Lisa B

机构信息

Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University, Stanford, California.

Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

出版信息

Clin Gastroenterol Hepatol. 2023 Dec;21(13):3440-3443.e2. doi: 10.1016/j.cgh.2023.01.010. Epub 2023 Jan 31.

DOI:10.1016/j.cgh.2023.01.010
PMID:36731586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10387494/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1c3/10387494/c401d422d0af/nihms-1905282-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1c3/10387494/c401d422d0af/nihms-1905282-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1c3/10387494/c401d422d0af/nihms-1905282-f0001.jpg

相似文献

1
Geographic Variation in NAFLD Prevalence and Subspecialty Care Utilization Among Insured Adults in the United States.美国参保成年人中NAFLD患病率及专科护理利用情况的地域差异
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3440-3443.e2. doi: 10.1016/j.cgh.2023.01.010. Epub 2023 Jan 31.
2
Nonalcoholic Fatty Liver Disease in Latinos. Latinos 中的非酒精性脂肪性肝病。
Clin Gastroenterol Hepatol. 2016 Jan;14(1):5-12; quiz e9-10. doi: 10.1016/j.cgh.2015.05.001. Epub 2015 May 11.
3
Surveillance for Health Care Access and Health Services Use, Adults Aged 18-64 Years - Behavioral Risk Factor Surveillance System, United States, 2014.18-64岁成年人医疗保健可及性与医疗服务利用情况监测——美国行为危险因素监测系统，2014年
MMWR Surveill Summ. 2017 Feb 24;66(7):1-42. doi: 10.15585/mmwr.ss6607a1.
4
[Non alcoholic fatty liver: a growing epidemic].非酒精性脂肪肝：日益流行的疾病
Rev Gastroenterol Peru. 2016 Jul-Sep;36(3):195-196.
5
Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.妊娠非酒精性脂肪性肝病与不良的母儿围生结局相关。
J Hepatol. 2020 Sep;73(3):516-522. doi: 10.1016/j.jhep.2020.03.049. Epub 2020 Jun 9.
6
Depression is associated with non-alcoholic fatty liver disease among adults in the United States.抑郁与美国成年人的非酒精性脂肪性肝病有关。
Aliment Pharmacol Ther. 2019 Sep;50(5):590-598. doi: 10.1111/apt.15395. Epub 2019 Jul 22.
7
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.美国非酒精性脂肪性肝病的患病率以及晚期肝纤维化和死亡的危险因素
PLoS One. 2017 Mar 27;12(3):e0173499. doi: 10.1371/journal.pone.0173499. eCollection 2017.
8
Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016.非酒精性脂肪性肝病在 2007-2016 年期间美国青少年和年轻人中的流行趋势。
Hepatol Commun. 2021 Oct;5(10):1676-1688. doi: 10.1002/hep4.1760. Epub 2021 Jul 1.
9
Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.美国成年人尿液中双酚 A 水平升高与非酒精性脂肪肝有关。
Liver Int. 2019 Jul;39(7):1335-1342. doi: 10.1111/liv.14110. Epub 2019 Apr 15.
10
Health Care Utilization Rates After Oregon's 2008 Medicaid Expansion: Within-Group and Between-Group Differences Over Time Among New, Returning, and Continuously Insured Enrollees.俄勒冈州2008年医疗补助扩大后的医疗服务利用率：新参保者、重新参保者和持续参保者随时间变化的组内和组间差异
Med Care. 2016 Nov;54(11):984-991. doi: 10.1097/MLR.0000000000000600.

引用本文的文献

1
Clinical and Economic Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Spanish Mediterranean Region: A Population-Based Study.西班牙地中海地区代谢功能障碍相关脂肪性肝病（MASLD）的临床和经济负担：一项基于人群的研究
J Clin Med. 2025 Apr 3;14(7):2441. doi: 10.3390/jcm14072441.
2
Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis (2000-2019).非酒精性脂肪性肝病对脓毒症住院患者预后的影响：一项全国性样本分析（2000 - 2019年）
J Clin Med. 2024 Sep 26;13(19):5737. doi: 10.3390/jcm13195737.
3
Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.

本文引用的文献

1
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者风险分层与管理的临床护理路径。
Gastroenterology. 2021 Nov;161(5):1657-1669. doi: 10.1053/j.gastro.2021.07.049. Epub 2021 Sep 20.
2
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.基于电子健康档案的 NAFLD 研究中的行政编码：专家小组共识声明。
Hepatology. 2021 Jul;74(1):474-482. doi: 10.1002/hep.31726. Epub 2021 Jun 22.
3
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
了解初级保健医生对非酒精性脂肪性肝病诊断和管理的观点：一项定性研究。
Inquiry. 2024 Jan-Dec;61:469580241241272. doi: 10.1177/00469580241241272.
4
Increasing prevalence of cirrhosis among insured adults in the United States, 2012-2018.2012-2018 年美国参保成年人肝硬化发病率的上升趋势。
PLoS One. 2024 Feb 26;19(2):e0298887. doi: 10.1371/journal.pone.0298887. eCollection 2024.
非酒精性脂肪性肝病向肝硬化的进展率及肝硬化向失代偿和死亡率的进展：医疗保险数据的真实世界分析。
Aliment Pharmacol Ther. 2020 Jun;51(11):1149-1159. doi: 10.1111/apt.15679. Epub 2020 May 5.
4
Differences in referral patterns for rural primary care physicians from 2005 to 2016.2005 年至 2016 年农村基层医生转诊模式的差异。
Health Serv Res. 2020 Feb;55(1):94-102. doi: 10.1111/1475-6773.13244. Epub 2019 Dec 17.
5
Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults.美国成年人中肥胖、代谢综合征和糖尿病的流行率存在地域差异。
Nutr Diabetes. 2018 Mar 13;8(1):14. doi: 10.1038/s41387-018-0024-2.
6
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
7
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.年龄作为晚期非酒精性脂肪性肝病纤维化准确无创诊断的混杂因素。
Am J Gastroenterol. 2017 May;112(5):740-751. doi: 10.1038/ajg.2016.453. Epub 2016 Oct 11.
8
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
9
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.